Compare Edwards Lifesciences Corporation Common Stock (EW) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs RLX Technology Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while RLX Technology Inc trades at $1.72 (market cap $2.10B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 23.1× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.81% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | RLX | |
|---|---|---|
Market Cap | $48.56B | $2.10B |
Volume | 6,520,488 | 1,079,706 |
Sector | Health | Consumer Staples |
52-Week High | $95.18 | $2.57 |
52-Week Low | $72.65 | $1.68 |
Enterprise Value | $45.01B | $832.26M |
Typical Hold Time | — | 34 Days |
Dividend Yield | — | 5.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RLX Technology trades at $1.73, down 1.76% with a bearish technical signal. The stock recently hit 52-week lows amid margin compression despite 14.8% revenue growth in Q2 2026. Valuation appears reasonable with P/E of 15.55 and P/B below 1, but earnings misses in recent quarters raise execution concerns. International expansion now drives 70% of revenue following European acquisitions.
The outlook remains challenged by consecutive earnings misses and technical weakness, though discounted valuation and international growth provide potential upside. Key risks include sustained margin pressure and integration challenges from recent acquisitions. With only one analyst covering and maintaining a hold rating, institutional conviction appears limited.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
